Each HALCION Tablet, for oral administration, contains 0.25 mg of triazolam. Inactive ingredients: 0.25 mg-cellulose, corn starch, docusate.
A dose of 0.5 mg should be used only for exceptional patients who do not respond adequay to a trial of a lower dose since the risk of several adverse reactions increases with the size of the dose administered. A dose of 0.5 mg should not be exceeded. A dose of 0.125 mg may be found to be sufficient for some patients (e.g., low body weight). The recommended dose for most adults is 0.25 mg before retiring.
In addition to these untoward events for which estimates of incidence are available, the following adverse events have been reported in association with the use of HALCION and other benzodiazepines : amnestic symptoms ( anterograde amnesia with appropriate or inappropriate behavior), confusional states (disorientation, derealization, depersonalization, and/or clouding of consciousness), dystonia, anorexia, fatigue, sedation, slurred speech, jaundice, pruritus, dysarthria, changes in libido, menstrual irregularities, incontinence, and urinary retention.
Find patient medical information for Halcion Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Taking triazolam with opioid medications (such as codeine, hydrocodone ) may increase your risk of very serious side effects, including death. To lower your risk, your doctor should have you take the smallest dose of triazolam that works, and take it for the shortest possible time. Get medical help right away if any of these very serious side effects occur: slow/shallow breathing, unusual lightheadedness, severe drowsiness/ dizziness, difficulty waking up.
Although unlikely, this drug can rarely cause temporary short-term memory loss.
Easy to read patient leaflet for Halcion. Includes indications, proper use, special instructions, precautions, and possible side effects.
This is only a brief summary of general information about this medicine. You must talk with your healthcare provider for complete information about the risks and benefits of using this medicine. This information is not specific medical advice and does not replace information you receive from your health care provider. Only your health care provider has the knowledge and training to decide which medicines are right for you. Disclaimer: This information should not be used to decide whether or not to take this medicine or any other medicine.
Halcion is a psychiatric drug used to treat insomnia and sometimes to reduce anxiety before dental work. It is a benzodiazepine which means it is a sedative.
It falls into the nightmare category as withdrawal from it can be more difficult than heroin, which most know is gut-wrenching and horrendous. Halcion came in at number seven! These are pretty grim facts that clearly indicate that Halcion is a dangerous drug that can make you worse off than you were before. Hopefully this is graphic enough, but if not, there is more to be known about Halcion. On top of that, a recent study identified thirty-one drugs that are disproportionay linked to violent behavior.
Objectivity and full disclosure are not required so they are dropped and replaced with the drive for profits.
Triazolam (original brand name Halcion) is a central nervous system (CNS) depressant in the benzodiazepine class. It possesses pharmacological properties similar to those of other benzodiazepines, but it is generally only used as a sedative to treat severe insomnia.
The half-life of triazolam is only 2 hours making it a very short acting benzodiazepine drug. Triazolam has anticonvulsant effects on brain function. The pharmacological effects of triazolam are similar to those of most other benzodiazepines. The main pharmacological effects of triazolam are the enhancement of the neurotransmitter GABA at the GABA A receptor. Triazolam does not generate active metabolites. Triazolam is a short acting benzodiazepine, is lipophilic, and is metabolised hepatically via oxidative pathways.
Its use at low doses has been deemed acceptable by the American Food and Drug Administration (FDA) and several other countries.
Triazolam is a drug that is used non-medically: recreational use wherein the drug is taken to achieve a high or continued long-term dosing against medical advice.
A worsening of insomnia ( rebound insomnia ) compared to baseline may occur after discontinuation of triazolam, even following short-term single-nightly-dose therapy.